
Korean Partner & Collaborator Network
KHIDI collaborates with leading Korean research programs, healthcare institutions, and professional associations to strengthen Korea–U.S. collaboration in the bio-health sector.
KHIDI maintains a collaborative network of 11 partner organizations across four key sectors: national R&D programs, clinical research and healthcare, medical and academic networks, and industry associations. Through these partnerships, KHIDI USA facilitates research collaboration, knowledge exchange, and connections across the bio-health ecosystem.
These partnerships help connect Korea's bio-health ecosystem with opportunities and expertise in the United States.
Partner & Collaborator Organizations

Goverment & Public
-
KDDF
-
KMDF
-
KFRM
-
K-Health MIRAE Initiative
-
BIKO

Hospitals
-
KoNECT
-
Research-Driven Hospitals

Academia
-
KAPS
-
KAMC

Industry
-
K-DOC
-
KPBMA
Goverment & Public
KDDF
Korea Drug Development Fund
KDDF is a government-funded national R&D initiative dedicated to advancing innovative drug development in Korea. It supports therapeutic research and development across academia and the pharmaceutical industry, helping strengthen Korea’s drug development pipeline from early discovery through clinical development.
KMDF supports medical device innovation through a government-wide R&D initiative. It promotes the development and commercialization of advanced medical technologies by supporting research, product development, clinical evaluation, and regulatory processes, contributing to a sustainable medical device innovation ecosystem.
KMDF
Korea Medical Device Development Foundation
KFRM
Korean Fund for
Regenerative Medicine
KFRM supports national R&D initiatives to advance regenerative medicine technologies and their clinical applications. It oversees research planning, project management, and evaluation while promoting technology transfer, commercialization, and translational research. KFRM also facilitates collaboration among researchers, government agencies, and international partners to strengthen regenerative medicine innovation.
The K-Health MIRAE Initiative leads mission-oriented, high-risk, high-reward healthcare R&D under Korea's ARPA-H-inspired program. Its five strategic missions address health security, challenging diseases, advanced bio-health technologies, health and care services, and critical care, supporting transformative innovation in healthcare.
K-Health MIRAE Initiative
BIKO
BioBigData.Korea
BIKO is a national initiative to establish an integrated biomedical data resource covering one million participants in Korea. By combining genomic, clinical, and other health-related data, the project aims to provide research infrastructure supporting disease prevention, precision medicine, drug development, and innovation across the bio-health industry.
Hospitals
KoNECT is a public-interest foundation dedicated to advancing Korea's clinical trial capabilities and drug development ecosystem. It supports clinical research infrastructure, workforce development, industry collaboration, and international clinical trial partnerships to strengthen Korea's competitiveness in global clinical research.
KoNECT
Korea National Enterprise for Clinical Trials
Research -Driven Hospitals
Research-Driven Hospitals are healthcare institutions recognized for integrating clinical practice with research and innovation. 21 hospitals have been certified under Korea’s national research-driven hospital program. These hospitals promote translational research, medical technology development, and collaboration among academia, healthcare, and industry.
Academia
KAPS is a professional organization dedicated to supporting the development of physician-scientists in Korea. It seeks to strengthen connections among medical professionals engaged in scientific research and foster an environment that supports the next generation of physician-scientists.
KAPS
Korean Association of Physician-Scientists
KAMC
Korea Association of Medical Colleges
KAMC is an organization representing medical education institutions in Korea. It promotes the advancement and quality of medical education through educational initiatives, academic activities, and institutional collaboration, contributing to the development of competent and well-rounded physicians.
Industry
K-DOC Inc. is a Korean healthcare company focused on expanding the global presence of Korean medical professionals and healthcare services. It provides overseas expansion consulting, international healthcare projects, and professional networking opportunities, connecting Korean medical expertise with healthcare markets around the world.
K-DOC
K-DOC Inc.
KPBMA
Korea Pharmaceutical and Bio-Pharma Manufacturers Association
KPBMA represents and supports Korea's pharmaceutical and biopharmaceutical industry. It promotes pharmaceutical innovation, industry collaboration, and global competitiveness through policy engagement, research initiatives, professional education, and international cooperation.